Based on our findings, we concluded that EMR1 upregulation in cancer cells is regulated by TAM and has a significant relationship with lymph node metastasis, and the combined EMR1-TC+CD68+CD163+ expression can be used as a prognostic indicator in patients with CRC. The gene discussed is CD68; the disease is cancer.